Australia markets closed

Chemomab Therapeutics Ltd. (CMMB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9124-0.0406 (-4.26%)
At close: 04:00PM EDT
0.9101 -0.00 (-0.25%)
After hours: 04:27PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
14,606
18,381
16,977
6,334
4,684
Selling general and administrative
5,852
7,078
11,556
6,033
1,288
Total operating expenses
20,458
25,459
28,533
12,367
5,972
Operating income or loss
-20,458
-25,459
-28,533
-12,367
-5,972
Income before tax
-19,357
-24,221
-28,180
-12,478
-5,951
Income tax expense
-21
0
-534
0
-
Income from continuing operations
-19,336
-24,221
-27,646
-12,478
-5,951
Net income
-19,336
-24,221
-27,646
-12,478
-5,951
Net income available to common shareholders
-19,336
-24,221
-27,646
-12,478
-5,951
Basic EPS
-2.94
-2.06
-2.42
-1.20
-0.54
Diluted EPS
-2.94
-2.06
-2.42
-1.20
-0.54
Basic average shares
11,210
11,750
11,379
10,373
11,003
Diluted average shares
11,210
11,750
11,379
10,373
11,003